Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
W. Richard Burack, M.D., Ph.D.
W. Richard Burack, M.D., Ph.D.

W. Richard Burack, M.D., Ph.D.

Pathology/Lab Medicine — Clinical Pathology — Clinical Pathology/Laboratory Medicine

Accepting New Patients

W. Richard Burack, M.D., Ph.D.

Pathology/Lab Medicine — Clinical Pathology — Clinical Pathology/Laboratory Medicine

Accepting New Patients


Locations

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 626
Rochester, NY 14642
Get Directions

phone

Appointments

(585) 275-8762

print

Fax

(585) 276-2390

About Me

Dr. Burack is the Vice Chair for Clinical Operations in the Department of Pathology and Laboratory Medicine. He directs the Hematopathology division, which includes the Flow Cytometry Laboratory, tissue banking activities, and the Hematopathology Fellowship Program. This division works closely with Wilmot Cancer Institute and Pediatric Oncology to evaluate and diagnose lymphomas, leukemias, and related disorders. Burack also directs the Molecular Genetic Pathology unit, which includes laboratories conducting diagnostic genetic tests, such as DNA sequencing and chromosomal analyses. Molecular Genetic Pathology supports the care of patients throughout the medical center, from Wilmot to Obstetrics.

Credentials

Education:

MD | University of Virginia School of Medicine — 1998
PhD | University of Virginia School of Medicine — 1994

Post-doctoral Training & Residency:

Residency in Clinical Pathology at University of Virginia School of Medicine — 1995 - 1998
Fellowship in Pathology at Barnes-Jewish Hospitals — 1998 - 1999

Research

Dr. Burack's research interests include the molecular mechanisms of lymphoma progression and development of molecular methods to refine diagnostics, particularly of lymphomas and leukemias. He recently became co-investigator on a grant to study the role of immune-senescence in lymphomagenesis, the role of immune microenvironment in determining response to therapy, and the role of immune function in the symptoms of lymphoma via analysis of rare immune cell populations by advanced flow cytometry.

Publications:

Patel N, Hoffman CM, Goldman BI, Bentley K, Burack WR, Evans AG. "Green Inclusions in Neutrophils and Monocytes Are an Indicator of Acute Liver Injury and High Mortality." Acta haematologica.. 2017 138(2):85-90. Epub 2017 Aug 17.

Youn P, Cummings MA, Dhakal S, Burack WR, Casulo C, Barr PM, Friedberg JW, Constine LS. "Prognostic Impact of Cell of Origin in Limited-Stage Diffuse Large B-Cell Lymphoma Treated With R-CHOP With or Without Radiation Therapy." International journal of radiation oncology, biology, physics.. 2016 Oct 1; 96(2S):E495.

Evans AG, Ahmad A, Burack WR, Iqbal MA. "Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.. 2016 Oct 0; 29(10):1183-99. Epub 2016 Jul 08.

View All Publications